Original news and analysis on international IP policy
From Infojustice.org: Letter from 56 Non-profit Organizations and Academic Experts to Secretary Kerry Regarding State Department Pressure Against Access to Medicines Efforts
The Médecins Sans Frontières (MSF) International Access Campaign is recruiting an Executive Director (ED) of the Access Campaign.
New documents reveal that the oil and tobacco industries took pages from the same book to engineer their decade long campaigns on denying the existence of climate change and smoking-related cancer. The playbook also appears to have originated not with tobacco, but with the oil industry itself, and the two even appeared to share patents.
The International AIDS Society made a statement today at the International AIDS Conference in Durban, South Africa, voicing concerns about India's recent policy which, according to the group, is threatening access to HIV treatment in India and around the world.
Small farmers around the world are threatened by new free trade agreements, a civil society group has argued. Those agreements go beyond the requirements of agreed international intellectual property rules and jeopardise the ability of small farmers to save, produce, and exchange seeds, the group said.
DURBAN, South Africa - The lessons derived from the history of AIDS treatment have become a rallying call for civil society organisations globally. Not being able to afford AIDS medicines should not be repeated for people with other diseases, including HIV co-infections, treatment activists told world leaders here.
The United Kingdom-based Anti-Counterfeiting Group (ACG) industry group launched a "manifesto" earlier this month, calling on the government to establish a more effective and comprehensive response to intellectual property crime.
A new report launched in time for this week's AIDS conference in South Africa analyzes factors relating to access to HIV/AIDS treatments over the past 15 years. The analysis includes a look at government policies used during that time, the contribution of generic and research-based industries, and the importance of voluntary licensing.
Worldwide sales for orphan drugs are forecast to reach $178 billion by 2020, according to a recent industry report. Moreover, the orphan drug market is expected to grow almost 12 percent per year, a level the broader pharmaceutical market “could only dream about” with its expected annual growth of 5.9 percent, according to Lisa Urquhart, editor of EvaluatePharma Vantage.
Days before a major meeting of the governing body of the United Nations Conference on Trade and Development (UNCTAD), over 100 non-governmental organisations worldwide are calling for the organisation to maintain its development role and not help implement international and regional trade rules.